The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
O'Hearn, E., Battaglia, G., De Souza, E., Kuhar, M., & Molliver, M. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02788.1988 · Cited by 542
Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.
Schmidt, C. J. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22673-8 · Cited by 529
Stone, D. M., Stahl, D. C., Hanson, G. R., & Gibb, J. W. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90555-8 · Cited by 346
Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance
Parrott, A. C., & Lasky, J. (1998) · Psychopharmacology · doi:10.1007/s002130050714 · Cited by 340
Functional Studies of the Central Catecholamines
Robbins, T. W., & Everitt, B. J. (1982) · International Review of Neurobiology · doi:10.1016/s0074-7742(08)60628-5 · Cited by 339
McCann, U. D., Ridenour, A., Shaham, Y., & Ricaurte, G. A. (1994) · Neuropsychopharmacology · doi:10.1038/npp.1994.15 · Cited by 332
Self-citationMDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons
Battaglia, G., Yeh, S. Y., & De Souza, E. B. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90155-4 · Cited by 312
Fischer, C., Hatzidimitriou, G., Wlos, J., Katz, J., & Ricaurte, G. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-08-05476.1995 · Cited by 268
Self-citationRicaurte, G. A., Martello, A. L., Katz, J. L., & Martello, M. B. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11083-5 · Cited by 268
Self-citationCognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficits
Parrott, A. C., Lees, A., Garnham, N. J., Jones, M., & Wesnes, K. (1998) · Journal of Psychopharmacology · doi:10.1177/026988119801200110 · Cited by 223
Methylenedioxymethamphetamine: A potentially neurotoxic amphetamine analogue
Schmidt, C. J., Wu, L., & Lovenberg, W. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90140-8 · Cited by 202
The Walter Reed performance assessment battery.
Thorne, D. R., Genser, S., Sing, H. C., & Hegge, F. W. (1985) · PubMed · Cited by 198
Kilpatrick, I. C., Jones, M. W., & Phillipson, O. T. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb08506.x · Cited by 195
Schmidt, C. J., & Taylor, V. L. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90566-1 · Cited by 187
Krystal, J. H., Price, L. H., Opsahl, C., Ricaurte, G. A., & Heninger, G. R. (1992) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999209026070 · Cited by 168
Self-citationScheffel, U., Szabó, Z. R., Mathews, W. B., Finley, P. A., Dannals, R. F., Ravert, H. T., Szabo, K., Yuan, J., & Ricaurte, G. A. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199806)29:2<183::aid-syn9>3.0.co;2-3 · Cited by 143
Self-citationMcCann, U. D., Ricaurte, G. A., & Ciraulo, D. A. (1991) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199110000-00005 · Cited by 134
Self-citationMcCann, U. D. (1997) · JAMA · doi:10.1001/jama.278.8.666 · Cited by 102
Self-citationNEWHOUSE, P. A. (1989) · Neuropsychopharmacology · doi:10.1016/0893-133x(89)90018-3 · Cited by 97
Cerebrospinal Fluid Studies of Neurotransmitter Function in Manic and Depressive Illness
Post, R. M., Ballenger, J. C., & Goodwin, F. K. (1980) · Springer eBooks · doi:10.1007/978-1-4684-1039-6_47 · Cited by 88
Ricaurte, G. A., DeLanney, L. E., Wiener, S. G., Irwin, I., & Langston, J. W. (1988) · Brain Research · doi:10.1016/0006-8993(88)90451-9 · Cited by 87
Self-citationThe Impact of Memory on Age Differences in Digit Symbol Performance
Erber, J. T., Botwinick, J., & Storandt, M. (1981) · Journal of Gerontology · doi:10.1093/geronj/36.5.586 · Cited by 78
Sleep deprivation and impaired cognition possible role of brain catecholamines
McCann, U. D., Penetar, D. M., Shaham, Y., Thorne, D. R., Gillin, J. C., Sing, H. C., Thomas, M. A., & Belenky, G. L. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90153-q · Cited by 48
Self-citationCerebrospinal Fluid Parameters in Healthy Volunteers During Serial Lumbar Punctures
Menachem, E. B., Persson, L., Schechter, P. J., Haegele, K. D., Huebert, N. D., & Hardenberg, J. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09166.x · Cited by 34
Reproducibility of monoamine metabolite measurements in human cerebrospinal fluid
Hildebrand, J. G., Bourgeois, F., Buyse, M. E., Przedborski, S., & Goldman, S. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1990.tb00989.x · Cited by 29
Cited by
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
Green, A. R., Mechan, A. O., Elliott, J. M., O’Shea, E., & Colado, M. I. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.3 · Cited by 1,272
Toxicity of amphetamines: an update
Carvalho, M., Carmo, H., Costa, V. M., Capela, J. P., Pontes, H., Remião, F., Carvalho, F., & Bastos, M. D. L. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0815-5 · Cited by 431
Ecstasy (MDMA): a review of its possible persistent psychological effects
Morgan, M. J. (2000) · Psychopharmacology · doi:10.1007/s002130000545 · Cited by 380
Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research
Parrott, A. C. (2001) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.351 · Cited by 344
Investigating the neurocognitive deficits associated with chronic drug misuse
Rogers, R. D., & Robbins, T. W. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00204-x · Cited by 344
Metadata
- Authors
- McCann, U. D., Mertl, M., Eligulashvili, V., & Ricaurte, G. A.
- Venue
- Psychopharmacology
- Published
- 1999-04-26
- Volume
- 143
- Issue
- 4
- Pages
- 417-425
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2127538073
- Cited by
- 300
- References
- 25
- FWCI
- 28.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.